TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation-Reference-Cited by-同舟云学术

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

Published:2022-10 Issue:4 Volume:77 Page:991-1004
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Labiano Ibone,Agirre-Lizaso Aloña,Olaizola Paula,Echebarria Anne,Huici-Izagirre Maider,Olaizola Irene,Esparza-Baquer Aitor,Sharif Omar,Hijona Elizabeth,Milkiewicz Piotr,Milkiewicz Malgorzata,González-Romero Francisco,Aspichueta Patricia,Monte Maria J.,Marin Jose J.G.,Vucur Mihael,Luedde Tom,Marzioni Marco,Mann Derek A.,Bujanda Luis,Rodrigues Pedro M.,Banales Jesus M.,Perugorria Maria J.

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Inflammation and cell death during cholestasis: the evolving role of bile acids;Woolbright;Gene Expr,2019

2. Management of cholestatic disease in 2017;de Vries;Liver Int,2017

3. Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?;Rodrigues;J Hepatol,2018

4. Current consensus on the management of primary sclerosing cholangitis;Wiencke;Clin Res Hepatol Gastroenterol,2011

5. Drug therapies for chronic cholestatic liver diseases;Wagner;Annu Rev Pharmacol Toxicol,2020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway;Phytomedicine;2024-11

2. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

3. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy;Frontiers in Cell and Developmental Biology;2024-09-05

4. Differential toxic and antiepileptic features of Vigabatrin raceme and its enantiomers;Brain Research;2024-09

5. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC;Gut Microbes;2024-08-06